Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.77B |
| 2 |
Microsoft
MSFT
|
+$1.65B |
| 3 |
NVIDIA
NVDA
|
+$1.47B |
| 4 |
Gilead Sciences
GILD
|
+$1.13B |
| 5 |
Kroger
KR
|
+$1.03B |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$1.34B |
| 2 |
Apple
AAPL
|
+$1.23B |
| 3 |
United Parcel Service
UPS
|
+$1.09B |
| 4 |
American Express
AXP
|
+$999M |
| 5 |
JPMorgan Chase
JPM
|
+$969M |
Sector Composition
| 1 | Technology | 24.89% |
| 2 | Financials | 15.95% |
| 3 | Healthcare | 15.37% |
| 4 | Consumer Discretionary | 9.68% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Cogent Biosciences
COGT
$1.77B
| $2.14M | ﹤0.01% |
297,364
+39,063
| +15% | +$280K |
|
1477
Mesa Laboratories
MLAB
$351M
| $2.12M | ﹤0.01% |
+22,471
| New | +$2.12M |
|
1478
Solventum
SOLV
$12.9B
| $2.12M | ﹤0.01% |
27,907
+170
| +0.6% | +$12.9K |
|
1479
Fortis
FTS
$24.6B
| $2.11M | ﹤0.01% |
44,334
-45,947
| -51% | -$2.19M |
|
1480
Flowers Foods
FLO
$3.15B
| $2.11M | ﹤0.01% |
132,160
+76,759
| +139% | +$1.23M |
|
1481
CorMedix
CRMD
$952M
| $2.11M | ﹤0.01% |
171,118
+7,169
| +4% | +$88.3K |
|
1482
First Merchants
FRME
$2.36B
| $2.1M | ﹤0.01% |
54,922
-11,337
| -17% | -$434K |
|
1483
Worthington Steel
WS
$1.63B
| $2.08M | ﹤0.01% |
69,761
-4,578
| -6% | -$137K |
|
1484
Ambev
ABEV
$34.3B
| $2.07M | ﹤0.01% |
859,469
+578,340
| +206% | +$1.39M |
|
1485
West Fraser Timber
WFG
$6.01B
| $2.06M | ﹤0.01% |
28,084
+15,959
| +132% | +$1.17M |
|
1486
Electronic Arts
EA
$42B
| $2.04M | ﹤0.01% |
12,797
-19,104
| -60% | -$3.05M |
|
1487
Green Dot
GDOT
$766M
| $2.03M | ﹤0.01% |
188,324
-4,154
| -2% | -$44.8K |
|
1488
Concentrix
CNXC
$3.31B
| $2.02M | ﹤0.01% |
+38,259
| New | +$2.02M |
|
1489
Western Digital
WDC
$32.4B
| $1.98M | ﹤0.01% |
30,928
-46,013
| -60% | -$2.94M |
|
1490
Immunome
IMNM
$818M
| $1.97M | ﹤0.01% |
211,829
+58,818
| +38% | +$547K |
|
|
BBOT
1491
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$872M
| $1.97M | ﹤0.01% |
184,590
| – | – |
|
|
CNTA
1492
Centessa Pharmaceuticals
CNTA
$2.42B
| $1.96M | ﹤0.01% |
149,451
+10,684
| +8% | +$140K |
|
1493
Target
TGT
$41.6B
| $1.96M | ﹤0.01% |
19,846
+7,087
| +56% | +$699K |
|
1494
Wave Life Sciences
WVE
$1.21B
| $1.94M | ﹤0.01% |
297,887
-1,782
| -0.6% | -$11.6K |
|
1495
Ultrapar
UGP
$4.09B
| $1.91M | ﹤0.01% |
582,781
-6,840
| -1% | -$22.4K |
|
1496
Enliven Therapeutics
ELVN
$1.19B
| $1.89M | ﹤0.01% |
94,012
+9,312
| +11% | +$187K |
|
1497
Xeris Biopharma Holdings
XERS
$1.25B
| $1.86M | ﹤0.01% |
399,291
+7,192
| +2% | +$33.6K |
|
1498
Amylyx Pharmaceuticals
AMLX
$931M
| $1.85M | ﹤0.01% |
288,618
-2,064
| -0.7% | -$13.2K |
|
1499
Theravance Biopharma
TBPH
$701M
| $1.85M | ﹤0.01% |
167,429
+12,000
| +8% | +$132K |
|
1500
Williams-Sonoma
WSM
$24.8B
| $1.84M | ﹤0.01% |
11,268
+2,391
| +27% | +$391K |
|